2009, Licensing, Pharmacy and Testimonials

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2009

Licensing

Pharmacy

Testimonials

Analysis Life Sciences Thank You The 51 regulations that FDA is currently working on

Agency IQ

JUNE 16, 2023

to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. The rule, will also, if finalized, address communication with State boards of pharmacy. The final rule will amend the administrative destruction provisions in 21 CFR 1.94

Regulations

Regulations FDA Science Production

The FDA and Feasible Alternative Designs

Drug & Device Law

FEBRUARY 20, 2023

Without an FDA license to produce another design, [defendant] was legally prohibited from distributing either [alternative design advocated by plaintiffs] at the time [plaintiff] received her vaccinations. In at least the short term, a popular pain reliever would have to be removed from pharmacies. Wyeth Laboratories, Inc. ,

FDA

FDA FDA Approval Testimonials Vaccine

Drug Discovery Digest

Analysis Life Sciences Thank You The 51 regulations that FDA is currently working on

The FDA and Feasible Alternative Designs

Stay Connected